BC Platforms (BCP), a global leader in healthcare data management and analytics, today announces the appointment of Alex Ide as the company’s Executive Vice President (EVP) of Sales for the UK.
In this pivotal role, Alex will be overseeing the customer-facing work underpinning the company’s commercial success through acquisition of new clients in a major market pioneering precision medicine. BC Platforms’ vision is to build a world leading analytics platform and data access service offering that enables the advancement of RWD usage by the pharmaceutical industry for their research processes.
Working closely with BCP’s leadership, and using his deep UK market expertise, Alex will drive the development and implementation of the company’s commercial strategy, which will accelerate BCP’s UK sales growth, and enhance the value clients receive from the company’s wide range of services.
Alex Ide, newly appointed EVP of Sales for the UK at BC Platforms, commented on his appointment, “I am excited to join the BC Platforms team to support the growth of its pharmaceutical and healthcare clients in the UK, one of our biggest markets. Our services, which include the sourcing and supporting of strategic use of patient data in clinical trials, are at the heart of helping our clients to deliver better treatments and patient care. I am looking forward to helping our industry do so much more with real world data, including enabling more informed decision making, and guiding precision medicine for better patient outcomes.”
Tero Silvola, Chief Executive Officer at BC Platforms, said, “We are delighted to welcome Alex, a proven leader in the healthcare field, as another great addition to our international team. He brings a more nuanced global representation to a key market for our world-leading services that bring together real world data from around the globe, and leveraging this to enhance, and complete, frameworks for the delivery of personalized medicines.”
Alex is based in the South West of England, and is a healthcare executive with 20 years of experience in tech start-ups, large multinationals, and private partnerships. Alex has operated in functional leadership and business development roles across the scientific and commercial spectrums with global, regional, and national level clients at pharmaceutical, biotech, and medical device companies. Prior to BC Platforms, Alex worked at Prospection, IQVIA, and ZS. Alex holds an MChem Chemistry degree from The Queen’s College, University of Oxford.